ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 674103 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 674103; 2) Community: the network communities that were significantly associated with the response to NSC 674103; 3) Molecule: the relationships between components within communities and NSC 674103; 4) MDR: the compounds that were significantly associated with the NSC 674103.

NSC Compound Enrichment Correlation
NSC 678925 1-Phenazinecarboxamide, N-[2-(dimethylamino)ethyl]- 9-fluoro-, monohydrochloride 0.0130238833303634 0.099294422
NSC 681239 Bortezomib 0.0130238833303634 -0.046787464
NSC 681636 Camptothecin Derivative 0.0130238833303634 0.2976109
NSC 682763 Null 0.0130238833303634 0.16670718
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0130238833303634 0.052175246
NSC 688021 Phosphorodiamidic acid, N,N-bis(2-bromoethyl)-, (5-nitro-2-thienyl)methyl ester 0.0130238833303634 0.3243706
NSC 691243 Null 0.0130238833303634 0.17807365
NSC 695941 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate 0.0130238833303634 0.12426334
NSC 696558 N-(4-Amino-4-deoxy-N10-methypteroyl)-D,L-homocysteic acid 0.0130238833303634 0.35501639
NSC 697653 Null 0.0130238833303634 0.32575671
Total:84  Current:28    [First] [Prev] [Next] [Last]